Surface Oncology (NASDAQ: SURF) today announced the presentation of updated preclinical findings regarding the anti-tumor effects of increasing inflammation and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE